DermTech Inc (NAS:DMTK)
$ 0.638 0.018 (2.9%) Market Cap: 22.31 Mil Enterprise Value: 20.21 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 44/100

DermTech Inc at UBS Global Healthcare Virtual Conference Transcript

May 24, 2021 / 08:00PM GMT
Release Date Price: $38.27 (+4.85%)
Abhinav Saxena

Good afternoon, and thank you for coming to the 2021 virtual UBS Global Healthcare Conference. My name is Abhinav Saxena, and I'm happy to be your host for this session. Our next presenter will be John Dobak, Chief Executive Officer; and Kevin Sun, Chief Financial Officer from DermTech. A Q&A session will follow immediately after the session. (Operator Instructions).

We now turn it over to John.

John D. Dobak
DermTech, Inc. - President, CEO & Director

Thank you, Abhinav, and thank you, UBS, for having us participate in this week's conference. My name is John Dobak. I'm the CEO of DermTech, and I'm happy to present to you our corporate story.

This is our standard SEC disclaimer information regarding forward-looking statements. I always like to start off our presentation talking about our leadership team.

This is Slide 3. We have a tremendous leadership team, we've been working together for several years. Our leaders hail from companies like Allergan and Dexcom and Insight and Ancestry.

We have deep

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot